Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

NCT01820260 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Ingenol mebutate gel
DRUG: placebo

Sponsor

LEO Pharma